SCYNEXIS Inc (SCYX)
1.565
-0.06
(-3.99%)
USD |
NASDAQ |
Sep 20, 16:00
1.56
0.00 (0.00%)
After-Hours: 20:00
SCYNEXIS Cash from Operations (Quarterly): -10.86M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -10.86M |
| March 31, 2024 | -4.007M |
| December 31, 2023 | -7.735M |
| September 30, 2023 | 12.42M |
| June 30, 2023 | 74.40M |
| March 31, 2023 | -18.92M |
| December 31, 2022 | -22.81M |
| September 30, 2022 | -22.51M |
| June 30, 2022 | -18.58M |
| March 31, 2022 | -15.99M |
| December 31, 2021 | -25.52M |
| September 30, 2021 | -16.59M |
| June 30, 2021 | -11.70M |
| March 31, 2021 | -0.759M |
| December 31, 2020 | -16.57M |
| September 30, 2020 | -9.869M |
| June 30, 2020 | -8.856M |
| March 31, 2020 | -14.06M |
| December 31, 2019 | -13.46M |
| September 30, 2019 | -10.40M |
| June 30, 2019 | -7.758M |
| March 31, 2019 | -6.501M |
| December 31, 2018 | -6.058M |
| Date | Value |
|---|---|
| September 30, 2018 | -6.148M |
| June 30, 2018 | -7.898M |
| March 31, 2018 | -8.219M |
| December 31, 2017 | -5.158M |
| September 30, 2017 | -5.245M |
| June 30, 2017 | -7.381M |
| March 31, 2017 | -6.772M |
| December 31, 2016 | -4.554M |
| September 30, 2016 | -6.848M |
| June 30, 2016 | -8.991M |
| March 31, 2016 | -8.96M |
| December 31, 2015 | -5.982M |
| September 30, 2015 | -5.744M |
| June 30, 2015 | -8.272M |
| March 31, 2015 | -4.547M |
| December 31, 2014 | -1.721M |
| September 30, 2014 | -3.683M |
| June 30, 2014 | -4.229M |
| March 31, 2014 | 0.161M |
| December 31, 2013 | -1.328M |
| September 30, 2013 | -0.146M |
| June 30, 2013 | -0.982M |
| March 31, 2013 | -1.851M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-25.52M
Minimum
Dec 2021
74.40M
Maximum
Jun 2023
-8.118M
Average
-12.58M
Median
Cash from Operations (Quarterly) Benchmarks
| Inogen Inc | 6.689M |
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -3.654M |
| Theriva Biologics Inc | -3.452M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 1.372M |
| Free Cash Flow | -10.18M |
| Free Cash Flow Per Share (Quarterly) | -0.2239 |
| Free Cash Flow to Equity (Quarterly) | -23.64M |
| Free Cash Flow to Firm (Quarterly) | -10.86M |
| Free Cash Flow Yield | -13.45% |